XML 77 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1

Business Combination (Details) - Schedule of the Acquisition-Date Fair Value of Each Major Class of Purchase - Holigen Holdings Limited and RPK Biopharma Unipessoal, LDA [Member] - USD ($)	Dec. 31, 2022	Apr. 29, 2022
Business Combination (Details) - Schedule of the Acquisition-Date Fair Value of Each Major Class of Purchase [Line Items]
Cash	$ 2,600,000	$ 2,600,000
Holdback payable	400,000	$ 400,000
Fair value of 190,000 common shares of the Company	16,131,000
Total consideration	$ 19,131,000

X

- References

No definition available.

+ Details

Name:	akan_BusinessCombinationDetailsScheduleoftheAcquisitionDateFairValueofEachMajorClassofPurchaseLineItems
Namespace Prefix:	akan_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the amount of liability for holdback payable, current.

+ References

No definition available.

+ Details

Name:	akan_HoldbackPayable
Namespace Prefix:	akan_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph f
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_CashTransferred
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph f
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_EquityInterestsOfAcquirer
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Details

Name:	ifrs-full_BusinessCombinationsAxis=akan_HoligenHoldingsLimitedAndRpkBiopharmaUnipessoalLdaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: